Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methyltransferase-like protein 25B (METTL25B) is a predicted RNA methyltransferase enzyme believed to catalyze rRNA (adenine-N6,N6-)-dimethyltransferase activity, indicating a probable role in the methylation of ribosomal RNA. While its precise biological functions are not well characterized, it is annotated to be involved in rRNA methylation, similar to other members of the METTL (Methyltransferase-like) protein family. There is no current experimental evidence strongly linking METTL25B to therapeutic targeting, drug interactions, or clinical safety concerns. Its disease association is limited to genetic syndromes identified in database annotations, with no clear mechanistic disease role described at this time[1][4][5][8][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyltransferase-like protein 25B (METTL25B).